We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Akamai
AKAM
$15.2B
| $42.9K | ﹤0.01% |
476
-65
| -12% | -$6.29K |
|
1627
Loews
L
$22.2B
| $42.8K | ﹤0.01% |
573
-2,154
| -79% | -$163K |
|
1628
iShares Russell 3000 ETF
IWV
$20.1B
| $42.6K | ﹤0.01% |
138
+81
| +142% | +$24.2K |
|
|
OSG
1629
Octave Specialty Group
OSG
$216M
| $42.5K | ﹤0.01% |
3,317
-5,061
| -60% | -$77.2K |
|
|
TDAY
1630
USA Today Co
TDAY
$973M
| $41.8K | ﹤0.01% |
9,061
+248
| +3% | +$830 |
|
|
PTVE
1631
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $40.8K | ﹤0.01% |
3,605
+1,474
| +69% | +$19.6K |
|
1632
KeyCorp
KEY
$22.8B
| $40.7K | ﹤0.01% |
2,861
-38,153
| -93% | -$554K |
|
|
LONA
1633
LeonaBio Inc
LONA
$64.8M
| $40.5K | ﹤0.01% |
1,527
+67
| +5% | +$1.58K |
|
1634
Enterprise Financial Services Corp
EFSC
$2.27B
| $39.4K | ﹤0.01% |
962
-906
| -49% | -$35.2K |
|
1635
Terreno Realty
TRNO
$7.22B
| $39.3K | ﹤0.01% |
664
| – | – |
|
|
AAT
1636
American Assets Trust
AAT
$1.34B
| $38.9K | ﹤0.01% |
1,738
| – | – |
|
1637
Helmerich & Payne
HP
$4.27B
| $38.4K | ﹤0.01% |
1,062
+129
| +14% | +$4.96K |
|
1638
News Corp Class A
NWSA
$16.3B
| $38.2K | ﹤0.01% |
1,387
-59
| -4% | -$1.52K |
|
|
WIRE
1639
DELISTED
Encore Wire Corp
WIRE
| $38K | ﹤0.01% |
131
-7,892
| -98% | -$2.22M |
|
1640
Pathward Financial
CASH
$1.64B
| $37.8K | ﹤0.01% |
668
-29
| -4% | -$1.52K |
|
1641
Columbus McKinnon
CMCO
$471M
| $37.8K | ﹤0.01% |
1,093
-411
| -27% | -$16.7K |
|
1642
IES Holdings
IESC
$12.9B
| $37.5K | ﹤0.01% |
538
+388
| +259% | +$27.3K |
|
1643
Viatris
VTRS
$19.5B
| $37.3K | ﹤0.01% |
3,512
-20,857
| -86% | -$230K |
|
1644
Korn Ferry
KFY
$4.25B
| $36.1K | ﹤0.01% |
538
-57
| -10% | -$3.66K |
|
1645
CBIZ
CBZ
$2.97B
| $35.8K | ﹤0.01% |
483
-27
| -5% | -$2.04K |
|
1646
Pool Corp
POOL
$6.24B
| $35.6K | ﹤0.01% |
116
-338
| -74% | -$122K |
|
1647
Patrick Industries
PATK
$2.31B
| $35.3K | ﹤0.01% |
488
+92
| +23% | +$6.73K |
|
1648
Clarus
CLAR
$135M
| $35.1K | ﹤0.01% |
5,222
-283,961
| -98% | -$1.87M |
|
1649
Bright Horizons
BFAM
$3.38B
| $35.1K | ﹤0.01% |
319
-122
| -28% | -$13.2K |
|
1650
Greenlight Captial
GLRE
$489M
| $35.1K | ﹤0.01% |
2,678
+239
| +10% | +$3.05K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.